Zolpidem is an imidazopyridine hypnotic with preferential binding affinity
for the omega(1)-benzodiazepine (BZD) receptor. The present double-blind, p
lacebo-controlled study evaluated the effects of orally administered zolpid
em (15 mg/70kg) on specific memory functions in 16 healthy volunteers using
a battery of word and picture memory tasks. Relative to placebo, zolpidem
significantly impaired memory for material presented after drug administrat
ion when memory was assessed directly by referring subjects back to the pri
or study episode (explicit memory: recall and recognition) but not when mem
ory was assessed indirectly by evaluating subjects' ability to identify deg
raded versions of studied stimuli (implicit memory: fragment completion). Z
olpidem did not impair explicit memory for material presented before drug a
dministration or memory for previously acquired knowledge (semantic memory:
categorization). There was evidence suggesting that zolpidem enhanced expl
icit and implicit memory for material presented before drug administration
and that zolpidem produced a specific deficit in the acquisition of context
ual information about material presented after drug administration. Despite
zolpidem's unique pharmacological profile, the observed selectivity of zol
pidem's memory-impairing effects for particular functions appears qualitati
vely similar to the selectivity observed with classic BZDs in previous stud
ies.